Editorial Policies
All the submitted articles must comply in full with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.
Submitted articles will be assessed by expert editorial staff (External and in-house) as per accordance to peer review. The submitted articles is first processed by in-house editors followed by transfer to associate editor who has sound knowledge of the areas discussed in the article.
Associate editor decides the articles priority order, importance to the journals’ readership and fulfilment towards journals’ spectrum/scope.
Associate editor will quickly reject the articles, not complying with author guidelines or unable to get high priority order. Articles complying the journal guidelines, scope and priority order are reviewed by minimum two external reviewers with double blind review process.
Information related to editorial decision as to acceptance for submitted article will be provided within 3-5 weeks of submission.
Confidentiality
Editorial staff will maintain confidentiality of the submitted articles. Reviewers involved in review process required to maintain confidentiality of review process and not allowed to discuss article report or process to authors or any third party. Any articles submitted or under correspondence with Lawarence press journal, confidential content and referees’ report must not be posted in any public domain or any website without prior permission from the editorial office/staff.
Disclosure:
For the submitted article authors are sole responsible for disclosing all financial and personal relationships that might bias their work. Authors have to submit disclosure for any potential conflict of interest associated with submitted article. Individual studies received funds from any source either government, private or commercial firms information should along with or in cover letter.
Conflict of interests (COI):
For COI form and further details, please visit: International Committee of Medical Journal Editors
Piracy is defined as the unauthorized reproduction or use of ideas, data, or methods from others without adequate permission or acknowledgment. Again, deceit plays a central role in this form of misconduct. The intent of the perpetrator is the untruthful portrayal of the ideas or methods as his or her own.
Plagiarism is a form of piracy that involves the unauthorized use or close imitation of the language (figures, images, or tables) and thoughts of others and the representation of them as one’s own original work without permission or acknowledgment by the author of the source of these materials. Plagiarism generally involves the use of materials from others, but can apply to researchers’ duplication of their own previously published reports without acknowledgment (this is sometimes called self-plagiarism or duplicate publication).
Source: Council of Science editors
Policy:
Lawarence Press is associated with group of experienced and expert editors from the publication industry who will verify the originality of submitted papers apart from this the papers will scan with the help of the CrossCheck database. Any misconduct ends with initial rejection. In case if any misconduct found after publication of paper in a Lawarence press journal, the editorial office will contact author’s affiliated institute and funding agencies with bidirectional statement linked online to and from the original paper and linked to the plagiarised published paper with reference and plagiarized content will be marked.
Plagiarism may also leads to retraction of paper.
Duplicate or overlap publication:
Duplicate (or redundant) publication is the publication of a paper that is substantially similar to a published paper by the same author, without acknowledging the source and without obtaining the permission of the original copyright holder. (Source: ICMJE)
Paper submitted to Lawarence press journals must be original. Authors should declare any duplicate publications during the time of submission with proper citation of duplicate publications.
Lawarence press reserve rights to judge any duplicate publications.
Retraction and Errata:
Articles may be retracted or withdrawn by their authors, academic or institutional sponsor, editor or publisher, because of pervasive error or unsubstantiated or irreproducible data.
Policy:
Information will be displayed at the journals website stating that article is retracted wholly or partially. Retraction are indexed and linked to the original article (labelled and published in citable form).
Errata:
Errata are published in citable form and notice will appear on a numbered page in a subsequent issue of the journal in which the article was originally published.
All journals of Lawarence press follow NLM retraction policy.
For more details reading please visit: Errata, Retractions, Partial Retractions, Corrected and Republished Articles, Duplicate Publications, Comments (including Author Replies), Updates, Patient Summaries, and Republished (Reprinted) Articles Policy for MEDLINE.
Reprint:
Lawarence Press Journals occasionally republish (i.e., reprint) and if reprint than cited as “Republished from:” and “Republished. Link will be created between original article and republished article.
Training of Editors
Each Lawarence press journal title is assigned a managing and a section editor, received an initial training to detect any irregularities. Editorial staff will have time to time updates and training from our outsource partner companies for recent advancements in of publication process and technology.
Internal audit
For proper editorial management Lawarence press will carry internal audit from guest editors every two year to detect and prevent any breaches. Internal audit includes random and blind collection of articles and peer review by third party or guest editor.
Complaint policy:
Please registered you complaint at admin@lawarencpress.com
Lawarence Press author licence and open access policy:
Lawarence Press journals follows open and hybrid open access publishing model.
Open access:
Open access (OA) refers to online research outputs that are free of all restrictions on access (e.g., access tolls) and free of many restrictions on use (e.g. certain copyright and license restrictions).Read more at https://en.wikipedia.org/wiki/Open_access
Hybrid Open access: A hybrid open access journal is an subscription journal in which some of the articles are open access. This status typically requires the payment of a publication fee (also called an article processing charge or APC) to the publisher. Read more at https://en.wikipedia.org/wiki/Hybrid_open_access_journal
All open access articles in Lawarence Press are published under Creative Commons licences. CC BY licence allows unrestricted reuse of the article providing the author(s) and original source are properly cited.
Alternative Creative Commons open access licenses are available on request, please contact the editorial office.
All open access articles associated with Article Processing Charges (APC) and available freely on Lawarence press journals platform.
Fee waiver policy:
Partial fee waiver for submitted open access articles based on HINARI Countries and will considered on a case-by-case basis. Request for waiver should be made prior or during the article submission; request during the review process or during editing or after acceptance will not be considered.
Benefits of Open access:
1. Freely available to journals audience and readers
2. Increased readership
3. Increased citation with more impact as compared to subscription based
4. Greater world wide collaborative research
Self archiving policy:
After publication of open access article, Lawarence press encouraged authors to submit their final author copy to PubMedCentral, institution’s repositories, appropriate funding body’s archive or website.
Article published via hybrid (subscription model), Lawarence press encouraged authors to submit author’s version of accepted article to a repository for the audience six months after publication.
Reuse of published content:
Any reuse of Lawarence press published content/articles is subjected to permission from editorial office of Lawarence Press. Achieved content may not be re-used for any commercial purpose or commercial advantage by the means of sale, resale, licence, loan, bulk promotion and other form of commercial promotions.
Any archived content of lawarence press may not be published verbatim in whole or in part, whether or not this is done for Commercial Purposes, either in print or online.
It is the moral responsibility that re-used content should be full attributed as a link of journals website from which content was re-used using article DOI.
Lawarence press restricted and applied prohibition for whole sale re-publishing.